Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Akizza 75mcg /30 mcg tablets

Active Ingredient:
ethinylestradiol, gestodene
Company:  
Morningside Healthcare Ltd See contact details
ATC code: 
G03AA10
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Patient Alert Card - Akizza 75mcg/30mcg Tablets

Important information for women about risk of blood clots with combined hormonal contraceptives.
{pdf_link}

Important Information leaflet - Akizza 75mcg/30mcg Tablets

All women should understand the small risk of blood clots with the combined hormonal contraceptives; what other conditions increase the risk of a blood clot; the signs and symptoms of a blood clot; when you need to tell a healthcare professional that you are using a combined hormonal contraceptive.
{pdf_link}

Checklist for Prescribers - Akizza 75 mcg 30 mcg tablets

{healthcare_pro_orange} For Healthcare Professionals
Please use this checklist in conjunction with the Summary of Product Characteristics during combined hormonal contraceptive (CHC) consultations

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Morningside Healthcare Ltd
Company image
Address
Morningside House, Unit C Harcourt Way, Meridian Business Park, Leicester, LE19 1WP
WWW
http://www.morningsidehealthcare.com
Telephone
+44 (0)116 204 5950
Medical Information Direct Line
+44 (0)116 478 0322
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)116 204 5950
Stock Availability
+44 (0)1509 217 705